| 1 |
Hu S, Liu L, Pollock RF, Pöhlmann J, Wu D, Zhang Y. Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose. Journal of Medical Economics. [DOI: 10.1080/13696998.2022.2065092] [Reference Citation Analysis]
|
| 2 |
Shao Y, Luo W, Xu H, Zhang L, Guo Q. The Efficacy of Ferumoxytol for Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials. Acta Haematol 2019;142:125-31. [PMID: 31434073 DOI: 10.1159/000498937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Argüelles-arias F, Bermejo F, Borrás-blasco J, Domènech E, Sicilia B, Huguet JM, de Arellano AR, Valentine WJ, Hunt B. Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain. Therap Adv Gastroenterol 2022;15:175628482210861. [DOI: 10.1177/17562848221086131] [Reference Citation Analysis]
|
| 4 |
Ueda N, Takasawa K. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease. Nutrients 2018;10:E1173. [PMID: 30150549 DOI: 10.3390/nu10091173] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 5 |
Kumar A, Brookes MJ. Iron Therapy in Inflammatory Bowel Disease. Nutrients 2020;12:E3478. [PMID: 33198376 DOI: 10.3390/nu12113478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Jimenez KM, Gasche C. Management of Iron Deficiency Anaemia in Inflammatory Bowel Disease. Acta Haematol 2019;142:30-6. [PMID: 30970351 DOI: 10.1159/000496728] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 7 |
Winckel K, Sullivan S, Vongphakdi M, Snoswell CL. A retrospective review examining intravenous iron infusion dosing methods. J Pharm Pract Res 2021;51:225-30. [DOI: 10.1002/jppr.1698] [Reference Citation Analysis]
|
| 8 |
Golonka RM, Xiao X, Abokor AA, Joe B, Vijay-Kumar M. Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota. J Nutr Biochem 2020;80:108360. [PMID: 32163821 DOI: 10.1016/j.jnutbio.2020.108360] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
|
